EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act

Naveed Sattar, Lindsey J Sattar, Iain B McInnes, Stefan Siebert, Lyn D Ferguson

Annals of the Rheumatic Diseases · 2025-06 · 84 (6) · 894-898

DOI: 10.1016/j.ard.2025.02.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of the Rheumatic Diseases, 2025-06. Verfasst von Naveed Sattar und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Electronic address: Naveed.Sattar@glasgow.ac.uk. Hauptthemen laut MEDLINE: Obesity, Rheumatic Diseases, Musculoskeletal Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a major health problem and risk factor for many chronic health conditions, including rheumatic and musculoskeletal diseases (RMDs). Around 7 in 10 adults with RMD live overweight or with obesity. Obesity not only increases the risk of developing RMDs. It worsens disease activity, pain, and fatigue; impairs treatment responses; and thereby reduces quality of life and physical function. Further, obesity can amplify or drive several comorbidities that are more prevalent in RMDs including hypertension, cardiovascular disease, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease. Moreover, reciprocal risk arises since RMDs make it harder to be physically active and maintain a healthy weight, especially in the context of an obesogenic environment. In this viewpoint, we review relevant evidence to suggest obesity confers distinctive, important challenges in care and daily living for many patients with RMDs. With the advent of several highly effective drugs for obesity, we also highlight research needs including that for robust clinical trials to test the efficacy and effectiveness of these therapies as part of the management of inflammatory RMDs, as primary agent or adjuvant to immune targeted therapeutics. Implementing such weight management strategies should provide a much-needed holistic approach to the care of our patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityRheumatic DiseasesMusculoskeletal DiseasesHumansRisk FactorsQuality of LifeComorbidity

Autor:innen und Institutionen

  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Electronic address: Naveed.Sattar@glasgow.ac.uk.
  • Rheumatology Team, Queen Elizabeth Building, Glasgow Royal Infirmary, Glasgow, UK.
  • College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • School of Infection & Immunity, University of Glasgow, Glasgow, UK.
  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Zitieren

APA

Sattar, N., Sattar, L. J., McInnes, I. B., Siebert, S., & Ferguson, L. D. (2025). Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act. Annals of the Rheumatic Diseases, 84(6), 894-898. https://doi.org/10.1016/j.ard.2025.02.013

Vancouver

Sattar N, Sattar LJ, McInnes IB, Siebert S, Ferguson LD. Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act. Annals of the Rheumatic Diseases. 2025;84(6):894-898. doi:10.1016/j.ard.2025.02.013

BibTeX
@article{Sattar2025,
  author = {Sattar, Naveed and Sattar, Lindsey J and McInnes, Iain B and Siebert, Stefan and Ferguson, Lyn D},
  title = {Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  volume = {84},
  number = {6},
  pages = {894--898},
  doi = {10.1016/j.ard.2025.02.013}
}
Kostenlos starten →